FLORIAN MÜLLERSHAUSEN

Florian Müllershausen is a distinguished Managing Director at the Novartis Venture Fund, a leading corporate venture capital firm dedicated to investing in and nurturing innovative life science companies. In this crucial role, Florian is instrumental in shaping the fund's investment strategy, identifying promising startups, and guiding them through their growth phases to bring transformative medical solutions to patients worldwide.

At the Novartis Venture Fund, Florian's investment focus spans a broad spectrum of the life sciences sector. He actively seeks out companies developing novel therapeutics, cutting-edge biotechnologies, and disruptive health technologies. His expertise is particularly valuable in evaluating early-stage opportunities that demonstrate strong scientific merit, significant unmet medical needs, and the potential for substantial impact. The fund's mandate, and by extension Florian's work, is to support ventures that complement Novartis's core research and development areas, including but not limited to oncology, neuroscience, immunology, cardiovascular and metabolic diseases, and gene therapy.

Florian Müllershausen's career background reflects a deep understanding of both scientific innovation and strategic business development within the pharmaceutical and biotech industries. His journey has equipped him with a unique perspective on the challenges and opportunities inherent in translating scientific discoveries into viable commercial products. This blend of scientific acumen and business foresight enables him to effectively assess complex investment proposals and provide invaluable guidance to portfolio companies. He is known for his commitment to fostering entrepreneurship and building strong relationships with founders and scientific leaders.

While specific individual investments are often part of the fund's broader portfolio, Florian plays a key role in the Novartis Venture Fund's overall success in backing companies that have gone on to achieve significant milestones, including successful clinical trials, regulatory approvals, and strategic partnerships. His work contributes directly to the fund's mission of accelerating innovation that can ultimately improve human health. Through his leadership and strategic insights, Florian Müllershausen continues to be a driving force in the life sciences investment landscape, helping to bring forward the next generation of medical breakthroughs.